• This record comes from PubMed

Hereditární hemoragická teleangiektázie (syndrom Osler-Weber-Rendu) Díl I. Patofyziologie, klinické příznaky a doporučený skrínink cévních malformací
[Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations]

. 2021 Winter ; 67 (6) : 339-344.

Language Czech Country Czech Republic Media print

Document type Journal Article

Links

PubMed 35459376
PII: 130094

Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation. Patients with HHT may have telangiectasias and later may develop arteriovenous malformations in various organs. Pacients suffer from many complications caused by the malformations and therefore by patients with HHT must by performed screening of this arteriovenous malformations. Optimal treatment of this malformations is best delivered throught a multidisciplinary approach. Farmacological treatment is described in next paper.

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...